Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Z Rheumatol ; 77(7): 593-608, 2018 Sep.
Article in German | MEDLINE | ID: mdl-29955955

ABSTRACT

Lupus nephritis (LN) is a common major organ manifestation of systemic lupus erythematosus (SLE) and causes significantly increased morbidity and mortality. Thus, all patients with SLE should be regularly screened for LN. While new onset glomerular hematuria or proteinuria are suggestive for LN, a kidney biopsy is the gold standard for diagnosis and classification. The treatment of LN comprises strict blood pressure control and administration of hydroxychloroquine. Aggressive forms of LN require additional treatment with immunosuppressive induction therapy followed by a maintenance phase for several years. Given the high rate of disease recurrence, life-long follow-up control in specialized centers is necessary. Despite optimal care a significant proportion of patients still develop chronic kidney failure. Better disease activity markers as well as more potent and specific therapeutic agents are thus urgently needed.


Subject(s)
Kidney Failure, Chronic , Lupus Erythematosus, Systemic , Lupus Nephritis , Humans , Immunosuppression Therapy , Immunosuppressive Agents/therapeutic use , Kidney Failure, Chronic/etiology , Lupus Nephritis/complications , Lupus Nephritis/diagnosis , Lupus Nephritis/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...